Page 33 - GPD-4-3

Gene & Protein in Disease TNFA polymorphism and risk of endometriosis

Total 6 c 7 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c 6 c

Non‑response rate 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b 0 b

Same method of ascertainment for cases and controls Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a Yes (1) a

Ascertainment of exposure 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a

Comparability of cases and controls on the basis of the design or analysis 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a

Definition of controls 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a

Selection of controls HB b PB a HB b HB b HB b HB b HB b HB b HB b HB b HB b HB b HB b HB b HB b

Representativeness of the cases 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a 1 a Notes: a Positive point; b Negative point/study excluded; c Study included.

Table 4. Quality assessment Is the case Study name definition adequate? 1 a Abutorabi et al. 26 1 a Asghar et al. 21 1 a Babaabasi et al. 27 1 a Chae et al. 18 1 a Drakou et al. 22 1 a Hsieh et al. 13 1 a Kublinsky et al. 16 1 a Lakshmi et al. 31 1 a Lee et al. 11 1 a Lee et al. 15 1 a Mardanian et al. 29 1 a Mier-Cabrera et al. 28 1 a Saliminejad et al. 20 1 a Teramoto et al. 30 1 a Wieser et al. 17 Abb

Volume 4 Issue 3 (2025) 7 doi: 10.36922/gpd.5204